Issue 7, 2020

An automated modular assembly line for drugs in a miniaturized plant

Abstract

We report here a fully automated, end-to-end, integrated continuous manufacturing process for a small-molecule generic medication with built-in quality assurance. The entire process fits into a box of 30.7 m2 modular footprint and a total residence time of less than 30 h, with a throughput up to 40.3 × 106 tablets per year.

Graphical abstract: An automated modular assembly line for drugs in a miniaturized plant

Supplementary files

Article information

Article type
Communication
Submitted
10 Sep 2019
Accepted
09 Dec 2019
First published
09 Dec 2019

Chem. Commun., 2020,56, 1026-1029

An automated modular assembly line for drugs in a miniaturized plant

C. Hu, C. J. Testa, W. Wu, K. Shvedova, D. E. Shen, R. Sayin, B. S. Halkude, F. Casati, P. Hermant, A. Ramnath, S. C. Born, B. Takizawa, T. F. O’Connor, X. Yang, S. Ramanujam and S. Mascia, Chem. Commun., 2020, 56, 1026 DOI: 10.1039/C9CC06945C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements